Raymond James & Associates’s Parexel International Corp PRXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-13,493
| Closed | -$1.19M | – | 3612 |
|
|
2017
Q3 | $1.19M | Sell |
13,493
-6,851
| -34% | -$600K | ﹤0.01% | 1991 |
|
|
2017
Q2 | $1.77M | Sell |
20,344
-1,865
| -8% | -$139K | ﹤0.01% | 1644 |
|
|
2017
Q1 | $1.4M | Sell |
22,209
-1,158
| -5% | -$76.6K | ﹤0.01% | 1771 |
|
|
2016
Q4 | $1.54M | Sell |
23,367
-8,028
| -26% | -$503K | ﹤0.01% | 1656 |
|
|
2016
Q3 | $2.18M | Buy |
31,395
+1,745
| +6% | +$118K | 0.01% | 1395 |
|
|
2016
Q2 | $1.86M | Buy |
29,650
+14,298
| +93% | +$885K | 0.01% | 1368 |
|
|
2016
Q1 | $963K | Buy |
15,352
+3,020
| +24% | +$186K | ﹤0.01% | 1684 |
|
|
2015
Q4 | $840K | Sell |
12,332
-21,363
| -63% | -$1.39M | ﹤0.01% | 1731 |
|
|
2015
Q3 | $2.09M | Buy |
33,695
+5,209
| +18% | +$350K | 0.01% | 1195 |
|
|
2015
Q2 | $1.83M | Buy |
28,486
+2,878
| +11% | +$194K | 0.01% | 1370 |
|
|
2015
Q1 | $1.77M | Sell |
25,608
-15,727
| -38% | -$1M | 0.01% | 1308 |
|
|
2014
Q4 | $2.3M | Buy |
41,335
+2,585
| +7% | +$149K | 0.01% | 1080 |
|
|
2014
Q3 | $2.44M | Buy |
38,750
+6,484
| +20% | +$370K | 0.01% | 1005 |
|
|
2014
Q2 | $1.71M | Buy |
32,266
+384
| +1% | +$19.3K | 0.01% | 1186 |
|
|
2014
Q1 | $1.72M | Buy |
31,882
+5,794
| +22% | +$297K | 0.01% | 1117 |
|
|
2013
Q4 | $1.18M | Buy |
26,088
+11,697
| +81% | +$535K | 0.01% | 1235 |
|
|
2013
Q3 | $722K | Buy |
+14,391
| New | +$705K | 0.01% | 1419 |
|
Other funds holding PRXL
Raymond James & Associates's PRXL Position: Q4 2017 in Review
Raymond James & Associates sold out of Parexel International Corp (PRXL) in Q4 2017, closing a stake of 13,493 shares — an estimated $1.19M sold.
Raymond James & Associates first reported a position in PRXL in Q3 2013 and held it in 17 quarters. The position peaked at $2.44M in Q3 2014. 1 fund tracked by Wall St. Rank holds PRXL as of Q4 2017.
- Raymond James & Associates reported no remaining Parexel International Corp position as of Q4 2017 after selling out during the quarter.
- Raymond James & Associates sold 13,493 Parexel International Corp shares in Q4 2017, an estimated $1.19M.
- Raymond James & Associates first reported a position in Parexel International Corp in Q3 2013 and held it in 17 quarters.
- Raymond James & Associates's Parexel International Corp position peaked at $2.44M in Q3 2014.
- 1 fund tracked by Wall St. Rank held Parexel International Corp as of Q4 2017.
Based on Raymond James & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.